Document Detail


Are "treatment" bare metal stents superior to "control" bare metal stents? A meta-analytic approach.
MedLine Citation:
PMID:  18371468     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: It has been suggested that the benefits of drug-eluting stents compared to bare metal stents (BMS) have been overestimated in part because target lesion/vessel revascularization (TLR/TVR) rates in the BMS control group of these trials were spuriously high.
METHODS: We used meta-analytic techniques to systematically compare clinical event rates among patients treated with BMS in trials where BMS were the experimental (BMS(experimental)) rather than the control (BMS(control)) intervention. MEDLINE searches were performed to identify eligible randomized trials comparing either drug-eluting stents with BMS(control) or BMS(experimental) with balloon angioplasty in patients with nonacute coronary artery disease. Trial characteristics and 6- to 12-month rates for death, myocardial infarction, TLR/TVR, and major adverse cardiac events were extracted and assessed.
RESULTS: Eligible trials yielded 50 BMS cohorts: 19 in the BMS(control) group (4046 patients) and 31 in the BMS(experimental) group (5068 patients). Summary death and infarction rates did not differ between groups. The summary TLR/TVR rates were 16.2% (95% CI 13.5-19.3) versus 13.8% (95% CI 12.0-15.7) in BMS(control) versus BMS(experimental) groups, respectively (P = .15). Among 39 BMS cohorts with < or = 250 patients, TLR/TVR rates were significantly higher in BMS(control) versus BMS(experimental) groups (18.9% [95% CI 16.0-22.2] vs 13.7% [95% CI 11.5-16.3], P = .01). There were no between-group differences among larger BMS cohorts (P = .98).
CONCLUSIONS: Although overall clinical event rates did not differ in the BMS(control) and the BMS(experimental) groups, a higher rate of TVR/TLR was seen in the BMS(control) group among smaller trials.
Authors:
David M Kent; Thomas A Trikalinos
Related Documents :
17174178 - Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent i...
11492988 - The influence of stent length on clinical and angiographic outcome in patients undergoi...
10193738 - Geometric features of coronary artery lesions favoring acute occlusion and myocardial i...
21219558 - Lone atrial fibrillation: what is known and what is to come.
2955688 - Early reperfusion therapy improves left ventricular function after acute inferior myoca...
12539168 - Angiogenesis of the heart.
Publication Detail:
Type:  Comparative Study; Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural     Date:  2008-01-18
Journal Detail:
Title:  American heart journal     Volume:  155     ISSN:  1097-6744     ISO Abbreviation:  Am. Heart J.     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-03-28     Completed Date:  2008-04-18     Revised Date:  2014-09-08    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  624-9, 629.e1-2     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Coronary Disease / therapy*
Female
Humans
Male
Myocardial Revascularization / statistics & numerical data
Regression Analysis
Statistics, Nonparametric
Stents*
Grant Support
ID/Acronym/Agency:
K23 NS044929/NS/NINDS NIH HHS; K23 NS044929/NS/NINDS NIH HHS; K23 NS044929-02/NS/NINDS NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective ...
Next Document:  Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: a meta-analy...